Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Assets (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Assets for 16 consecutive years, with $5.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets fell 15.03% to $5.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.9 million, a 15.03% decrease, with the full-year FY2024 number at $6.7 million, down 37.76% from a year prior.
  • Assets was $5.9 million for Q3 2025 at Creative Medical Technology Holdings, down from $7.1 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $23.4 million in Q2 2022 to a low of $732309.0 in Q2 2021.
  • A 5-year average of $10.3 million and a median of $9.6 million in 2024 define the central range for Assets.
  • Peak YoY movement for Assets: soared 3100.04% in 2022, then tumbled 44.96% in 2024.
  • Creative Medical Technology Holdings' Assets stood at $11.3 million in 2021, then skyrocketed by 70.27% to $19.2 million in 2022, then tumbled by 44.15% to $10.7 million in 2023, then crashed by 37.76% to $6.7 million in 2024, then decreased by 12.24% to $5.9 million in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Assets are $5.9 million (Q3 2025), $7.1 million (Q2 2025), and $8.3 million (Q1 2025).